D. E. Shaw & Co »

Janux Therapeutics shares owned by D. E. Shaw & Co

Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by D. E. Shaw & Co from 13F filings

Historical chart of D. E. Shaw & Co investment in Janux Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Janux Therapeutics held by D. E. Shaw & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Janux Therapeutics by D. E. Shaw & Co

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.1M 55k 37.65
2022-03-31 $165k 12k 14.37
2021-12-31 $548k 28k 19.73
2021-09-30 $998k 46k 21.62

More positions owned by D. E. Shaw & Co

Microsoft Corporation Put Option (MSFT)
Apple Put Option (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A Call Option (META)
Netflix Put Option (NFLX)
Chipotle Mexican Grill (CMG)
Uber Technologies Put Option (UBER)
Tesla Motors (TSLA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Visa Com Cl A (V)
Booking Holdings (BKNG)
Pfizer Put Option (PFE)
Advanced Micro Devices Put Option (AMD)
Citigroup Com New (C)

View all positions for D. E. Shaw & Co

Top funds holding Janux Therapeutics

RA Capital Management
FMR
OrbiMed Advisors
BVF
Adage Capital Partners GP
Citadel Advisors
Henderson Group
BlackRock
Vanguard Group
Rtw Investments
Cormorant Asset Management
Lord, Abbett & Co
Geode Capital Management
State Street Corporation
Avidity Partners Management

View all funds holding Janux Therapeutics